← All companies
NTLA annual revenue
Intellia Therapeutics, Inc.
NTLA - CIK 0001652130
Market cap$1.73 B
Rank#2213
SEC filings687
Intellia Therapeutics, Inc. revenue by year
Intellia Therapeutics, Inc. (NTLA) reported revenue of $67.67M for fiscal year 2025, as filed in its audited annual report with the SEC.
NTLA revenue 2016-2025
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $67.67M | +16.9% |
| FY 2024 | $57.88M | +59.6% |
| FY 2023 | $36.27M | -30.4% |
| FY 2022 | $52.12M | +57.7% |
| FY 2021 | $33.05M | -43.0% |
| FY 2020 | $57.99M | +34.5% |
| FY 2019 | $43.10M | +41.6% |
| FY 2018 | $30.43M | +16.5% |
| FY 2017 |
Revenue of similar companies
Frequently asked questions
How much revenue does Intellia Therapeutics, Inc. make?
Intellia Therapeutics, Inc. (NTLA) reported revenue of $67.67M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has Intellia Therapeutics, Inc.'s revenue changed over time?
Between fiscal 2016 and fiscal 2025, Intellia Therapeutics, Inc.'s revenue grew from $16.48M to $67.67M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.